EOM 1352: Fri 7 June 2024, 11:36
Catalyst 7 July 2023, 14:52

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Europe

Hospital PUC-Campinas Celso Pierro joins Patient Network Explorer, expanding Clinerion’s existing patient coverage in Brazil

Hospital PUC-Campinas Celso Pierro joins the global hospital network on Patient Network Explorer, bringing its patients access to leading-edge medical interventions ...
Continue Reading →
Europe

Life sciences innovation on the rise: European Patent Office reports increase in patent filings in 2019

EPO Patent Index: pharmaceuticals and biotechnology see steady growth in European patent applicationsINSERM and Hoffmann-La Roche maintain their positions as top app...
Continue Reading →
Europe

Over half the nation ‘at risk’ of chronic disease due to obesity

A new NHS report has detailed how more than 56% of adults are at increased, high or very high risk of chronic disease due to their waist circumference and BMI, with ...
Continue Reading →
Europe

Lynparza shows benefits in prostate cancer

Lynparza (olaparib) continues to go from strength to strength, as the MSD and AstraZeneca PARP inhibitor has now been shown to slow or stop tumour growth in some men...
Continue Reading →
news

Merck’s Keytruda is bound for new bladder cancer territory. But can it hold up against gene therapy?

Currently, five PD-1/L1 inhibitors boast FDA approvals to treat certain bladder cancer patients. But only one of them is about to enter a different segment of the di...
Continue Reading →
Europe

Hypha Discovery announces “One-Stop Metabolite Shop” solution to support pharmaceutical and agrochemical R&D

 Hypha Discovery Limited, a leading specialist CRO, has launched its “One-Stop Metabolite Shop” to provide a complete solution for provision of small molecule drug m...
Continue Reading →
Europe

IONTAS and Adaptate Biotherapeutics collaborate to identify optimised antibodies for novel cancer targets

IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, today announced it has entered into a collaboration agreement with Ada...
Continue Reading →
Europe

Clinerion and Massive Bio partner to improve cancer patient lives

Clinerion, provider of the Patient Network Explorer platform which harnesses patient data from a global hospital network, and Massive Bio, provider of end-to-end pa...
Continue Reading →
news

Unique Alzheimer’s Disease Tau Vaccine Shows Great Potential in Pre-Clinical Studies

MultiTEP Platform-Based Epitope Vaccine Targeting the Phosphatase Activating Domain (PAD) of Tau Shows Clear Therapeutic Efficacy in PS19 Mice Capo Therapeutics, I...
Continue Reading →
news

TSI Reports Enrollment of First 10 Patients in its Phase 2 Ischemic Stroke Clinical Trial and Completion of its Phase 2 Study Protocol in Myocardial Infarction

Studies Aim to Confirm Safety and Efficacy of Novel Bio-inspired Clot-dissolving Therapy Thrombolytic Science, LLC (TSI) today announced progress with 10 patients ...
Continue Reading →
Catalyst: Fri 8 November 2024, 14:16
Biosynth: Wed 13 November 2024, 10:18